Skip to main content

Table 1 Characteristics of the 15 interviewees

From: HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection

Patient Age (yrs) Gender m/f/o Transmission mode Year CDC CD4 (%) Viral Load (log) HAART* Duration (mths)
1 48 m msm 1985 C 35 <40 3TC/AZT/ABC 109
2 31 m msm 2004 A 30 <40 3TC/AZT/EFV 42
3 41 f unknown 1987 B 22 <40 FTC/TDF/LPV/RTV 180
4 66 m hetero 1997 C 20 <40 3TC/DDI/RTV/ATV 114
5 28 f hetero 1994 C <6% 4.8 no current HAART 156
6 36 m msm 2003 A 28 1.84 3TC/AZT/NVP 33
7 55 m msm 1988 A 34 <40 3TC/ ABC/ LPV/RTV 78
8 47 m msm 2002 A 26 <40 3TC/ ABC/ LPV/RTV 36
9 45 m msm 2001 C 28 <40 3TC/TDF/NVP 72
10 38 m msm 2006 A 17 <40 3TC/AZT/EFV 9
11 26 f hetero 1998 A 49 <40 3TC/AZT/EFV 72
12 32 f IDU 2001 A 32 3.92 no current HAART 72
13 44 m msm 1986 C 21 2.16 3TC/AZT/ABC 156
14 37 m msm 2005 A 30 <40 3TC/ABC/RTV/ATV 26
15 42 m msm 2002 C 20 <40 3TC/AZT/EFV 63
  1. Abbreviations: msm = men who have sex with men, hetero= heterosexual, IDU = injecting drug use. HAART= highly active antiretroviral therapy; 3TC= lamivudine, FTC= emtricitabine, AZT= zidovudine, ABC = abacavir, TDF = tenofovir, DDI= didanosine, NVP= nevirapine, EFV= efavirenz, LPV=lopinavir, RTV= ritonavir, ATV= atazanavir; 8/13 patients on a BD regimen, mean number of pills = 3.4, median=3.
  2. CDC = stage at first presentation.